Phase I study of the PI3K/mTOR inhibitor PF-05212384 in combination with other antitumor agents

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 33; no. 15_suppl; p. 2590
Main Authors: Wainberg, Zev A., Shapiro, Geoffrey, Curigliano, Giuseppe, Leong, Stephen, Kristeleit, Rebecca Sophie, Alsina Maqueda, Maria, Britten, Carolyn D., Milella, Michele, Middleton, Mark R., Olszanski, Anthony J., Vaishampayan, Ulka N., Lopez-Martin, Jose A., Gelmon, Karen A., Brega, Nicoletta, Pierce, Kristen J., Perea, Rachelle, Houk, Brett Edward, Pathan, Nuzhat, Gollerkeri, Ashwin, Razak, Albiruni R. A.
Format: Journal Article
Language:English
Published: 20-05-2015
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.2590